0 TSX News - June 17, 2020Husky Energy Reports Results of Series 7 Preferred Share ConversionCALGARY, Alberta, June 17, 2020 (GLOBE NEWSWIRE) — Husky Energy (TSX: HSE) announces that 212,461 Cumulative Redeemable Preferred Shares, Series 7 […]Read More
0 TSX Venture News - June 17, 2020Plato Gold Corp. Announces Increased Size of Non-Brokered Private Placement and Final Closing for $153,500NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICESTORONTO, June 17, 2020 (GLOBE NEWSWIRE) — Plato […]Read More
0 NASDAQ Companies - June 17, 2020Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of FibromyalgiaSAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients […]Read More
0 NYSE Companies - June 17, 2020Progressive Reports May 2020 ResultsMAYFIELD VILLAGE, OHIO, June 17, 2020 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for May […]Read More
0 NASDAQ Companies - June 17, 2020AMERANT BANCORP INC. Announces Pricing of Senior Notes OfferingCORAL GABLES, Fla., June 17, 2020 (GLOBE NEWSWIRE) — AMERANT BANCORP INC. (NASDAQ: AMTB and AMTBB) (the “Company”) today announced […]Read More
0 NYSE Companies - June 17, 2020Isoray and University of Cincinnati Physicians Company Sign Research Agreement to Study Treatment of Head and Neck Cancers RICHLAND, Wash., June 17, 2020 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE American: ISR) today announced that it has entered into […]Read More
0 TSX Venture News - June 17, 2020Kintavar Drilling Results on Sherlock; Gold and Cobalt Trend Identified on Mitchi; Summer Exploration BeginsMONTREAL, June 17, 2020 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR) (FRANKFURT: 58V), is pleased […]Read More
0 NASDAQ Companies - June 17, 2020Outlook Therapeutics Provides Clinical Update on ONS-5010 / LYTENAVA™ (bevacizumab-vikg)Lead product candidate ONS-5010 / LYTENAVATM (bevacizumab-vikg) has potential to be first FDA-approved ophthalmic formulation of bevacizumab for use in […]Read More
0 NASDAQ Companies - June 17, 2020Windstream Partners with Infinera to Transmit 800G over 730 Km in Live Production Network Using ICE6 TechnologySUNNYVALE, Calif. and LITTLE ROCK, Ark., June 17, 2020 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) and Windstream, a leading provider […]Read More
0 NASDAQ Companies - June 17, 2020Kiniksa Announces Lancet Rheumatology Publication of Clinical Outcomes with Mavrilimumab in COVID-19HAMILTON, Bermuda, June 17, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, […]Read More